ArticleThe Journal of nutrition2026
Iron Deficiency Impairs Mitochondrial Energetics and Early Axonal Growth and Branching in Developing Hippocampal Neurons.
Article in The Journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
Corrections and comments
- Update of
Authors and funding
9 authors.
Funding
Abstract
backgroundEnergy deficits underlie many neurodevelopmental, neuropsychiatric, and neurodegenerative diseases implicating mitochondria as a potential therapeutic target. Iron is necessary for neuronal energy output through its direct role in mitochondrial oxidative phosphorylation. Iron deficiency (ID) reduces mitochondrial energetic capacity in developing hippocampal neurons and causes simplified dendritic arbors and impaired learning and memory.
objectivesThis study aimed to determine the effect of ID on axonogenesis, which has not been previously explored.
methodsWe used an embryonic mouse mixed-sex primary hippocampal neuron culture model of developmental ID, using iron chelation with low micromolar deferoxamine (DFO) from 3 d in vitro (DIV) to 7 DIV compared with untreated control cultures. Mitochondrial respiration and dynamics, cytoskeletal and metabolic gene expression, and axonal and synaptic morphology were quantified and compared using t-test, analysis of variance, and multivariate statistical analyses.
resultsSeven DIV DFO-treated neuron cultures (n = 4-17) demonstrated moderate ID with significantly decreased mRNA levels for genes involved in axon cytoskeletal development (Gda, Pfn2, and Nuak1; ∼20%-40% lower) and metabolic homeostasis (Ndufs1, Ddit4, and Slc2a3; ∼20%-25% lower). DFO significantly reduced total adenosine-5'-triphosphate production rate and measures of mitochondrial oxidative phosphorylation by ∼25% to 50% compared with control cultures (n = 11-14). DFO significantly reduced the length of the primary axon and axonal branches by ∼20%, without affecting branch number (n = 100 neurons). Axonal mitochondrial motility was not altered by ID (n = 11-12 neurons), suggesting that impaired mitochondrial energetics, and not trafficking, is the predominate mitochondrial contribution to axon morphological deficits. Ultimately, at 18 DIV, DFO significantly reduced the density of postsynaptic density puncta, a measure of neuronal capacity for synapse formation, by 30% (n = 26-32 neurons).
conclusionsThese findings provide the first link between iron-dependent neuronal energy production and early axon structural development and highlight the importance of maintaining sufficient iron during the embryonic period of rapid axonal growth to prevent the persistent negative consequences of ID on neuronal structure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.